Organized By
Department of Haematology, Christian Medical College, Vellore
IBMFS 2023 date and program will be announced soon.
IBMFS - Past Events
The presenting signs and symptoms of bone marrow failure disorders (BMFS) are varied and may be silent or mimic other common, less serious disorders, and therefore are often overlooked or misdiagnosed leading to suboptimal outcomes.
The Bone Marrow Failure Disorders Symposium will provide updates on the most recent research related to the biology and clinical management of bone marrow failure disorders, including aplastic anemia, Fanconi anemia, Diamond Blackfan anemia, myelodysplastic syndrome and other rarer bone marrow failure syndromes.
National and international haematology/oncology clinicians and researchers will deliver talks on the latest advances in the diagnosis, genetic characteristics, pathology and treatment options for these diseases. The overall goal of this symposium is to facilitate the translation of research findings into clinical practice and to improve the care of the patients with bone marrow failure diseases.
This program will use an integral mix of didactic presentations and case histories to depict the scope of effectively recognizing, diagnosing, and recommending treatments for a group of rare bone marrow failure diseases. The presentations will provide necessary background on the etiology, pathogenesis, differential diagnosis of these conditions and important treatment options.
Who it is aimed at?
1. Hematologists, Pediatricians, Pathologists and Scientists.
2. Researchers involved in understanding the biology and pathogenesis of bone marrow failure diseases.
3. MD and PhD students who are interested in understanding the biology, diagnosis and treatment of bone marrow failure diseases.
How will this benefit?
1. Provide accurate differential diagnosis of bone marrow failure diseases, including aplastic anemia (AA), Fanconi anemia (FA), Diamond Blackfan anemia (DBA), Myelodysplastic syndromes (MDS) and other inherited bone marrow failure syndromes (IBFMS).
2. Critically appraise recent advances in research on the genetic characteristics of bone marrow failure diseases.
3. Summarize recent progress in understanding the pathogenesis of bone marrow failure diseases.
4. Describe safety and efficacy data for currently available therapies for bone marrow failure diseases.
5. Identify current therapeutic standards, as well as new and emerging therapies used in hematopoietic cell transplantation.
Topics to be covered
1. Molecular basis and treatment of Fanconi anemia.
2. Pathophysiology and management of aplastic anemia.
3. How to distinguish idiopathic aplastic anemia from IBMFS.
4. Molecular pathology and management of low and high-risk MDS.
5. Application of cytogenetics, proteomics and genomics in bone marrow failure syndromes.